17 February 2003

Sense Proteomic and Procognia unite

Northbank gains one new client and welcomes back an old one

In January Northbank Communications was pleased to pick up the opportunity to provide PR support to Maidenhead, UK based Procognia Ltd. Initially PR work started with implementing the announcement of Procognia's acquisition of Sense Proteomic www.procognia.com. Coverage was achieved in many on and off-line journals and websites including BioSpace, BioFind, Tornado Insider, Invest in Biotech, BioCentury, Scrip, In Vivo Europe Rx and BioPortfolio.

Procognia is creating an integrated suite of technologies that will broadly enable all aspects of development of therapeutics, diagnostics and personalized medicine. Procognia ‘s integrated technologies will serve to increase the probability of success of many pharmaceutical products. The company's original technology is the rapid glycoanalysis of biopharmaceutical therapeutics. The glycolysation of biopharmaceutical products is one of the most difficult manufacturing processes to control and the analysis of the glycolysation pattern is a time consuming and labour intensive job. Procognia technology has automated this process and reduced it to take a few hours.

The Sense Proteomic acquisition complements and expands Procognia's technology suite by adding functional protein array capability. This array technology integrates the processes of cloning, expression and purification of functional proteins. The resulting arrays can be probed in multiple formats for binding, biological and biochemical activity in response to small molecules, other proteins, RNA or DNA. Until their acquisition by Procognia, Sense Proteomic was a client of Northbank's Manchester office. In that two year long relationship, Northbank assisted in developing Sense's corporate identity and accompanying corporate communications materials as well as a website and provided PR support.

back to news

© 2007 College Hill Associates | Registered in England No 1036926 / VAT No 245666930 | Legal